These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 10051291)

  • 1. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.
    Ridker PM; Hennekens CH; Miletich JP
    Circulation; 1999 Mar; 99(8):999-1004. PubMed ID: 10051291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
    CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
    Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
    Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
    Doggen CJ; Cats VM; Bertina RM; Rosendaal FR
    Circulation; 1998 Mar; 97(11):1037-41. PubMed ID: 9531249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
    Beye A; Pindur G
    Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
    Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
    Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS; Miletich JP; Goldhaber SZ; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2001 Jan; 37(1):215-8. PubMed ID: 11153741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
    Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci PM; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci PG; Biffi R; Orsi F; Cinieri S; Goldhirsch A
    Ann Oncol; 2004 Apr; 15(4):590-3. PubMed ID: 15033664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
    Van Rooden CJ; Rosendaal FR; Meinders AE; Van Oostayen JA; Van Der Meer FJ; Huisman MV
    Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis.
    Gutiérrez Tous MR; Couto Caro C; García-Donas Gabaldón G; Viloria Peñas Mdel M; Simón Pilo I; Almeida González C
    Med Clin (Barc); 2007 May; 128(17):652-4. PubMed ID: 17537362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.
    Ridker PM; Hennekens CH; Schmitz C; Stampfer MJ; Lindpaintner K
    Lancet; 1997 Feb; 349(9049):385-8. PubMed ID: 9033464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.